pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-122 |
Genomic Coordinates | chr18: 65248861 - 65248926 |
Synonyms | Mirn122a, mmu-mir-122, Mir122a |
Description | Mus musculus miR-122 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-122-5p |
Sequence | 6| UGGAGUGUGACAAUGGUGUUUG |27 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Rell1 | ||||||||||||||||||||
Synonyms | AA536743 | ||||||||||||||||||||
Description | RELT-like 1 | ||||||||||||||||||||
Transcript | NM_145923 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Rell1 | |||||||||||||||||||||
3'UTR of Rell1 (miRNA target sites are highlighted) |
>Rell1|NM_145923|3'UTR 1 CTGCAGCTGCTGGCTTTCTTGAAGAGTTCTAAGAGACTCCGAACTTGCGAGATAATGAAGTCGCCTAGGGAATATTTTTA 81 TATGTTTTATACAGTTTCTATCATGAAGTCAATGGGCATGCGGATCAAACCCAAAAGGGCATATTTTTGCTACGCTGGAC 161 ACAGAATTCAGCTTGCTTTGAAAGAAGCTTTGGGCTTAAAAGGTGTGATGAAAGTTTTAGTTCCGTTTCTAAAAGGGAAA 241 GAGCTCTTCCTTTTAGACAACCGTCCCCAGGTGCACATTCCTGGCTGTCCATACCCAGGCAGCTACTCCCTTGGAATCAT 321 GGCATTATGAACAAACAGAGGAGCCATTTCCAGCCTGAGCTTGTGTTGGCATGCTGACATCTGTTCCTGAACCCCAGATT 401 CCATGTTGACTTTGGCCCTAAGATCTTAATACACACAGTTGGGCTGTTACAGAAGACTCTTGCCTGCAAAAGGTCCCTGG 481 AAAACATCTAGTGCTTAGAAAATGATCCGCTAGGACGTCATGGGATCCAATGGAACCACAGGCGCCCTGCACTAAAGATT 561 CCTGGACCAACAAGAATTCAGCACTGACTCCTGCTCCCGTCAGCCTGCCCCCTGTCATTCTCTGGTCACTTAGAAGACAC 641 AGAGACTATGACTGTTGTTATGGACTTAATCTAAACAGCTGGCTTTTAGTCTGATTGAGTAAAAGGGAAAATGGTTTAAA 721 GGCAACCAAAGGCCAAAACAAAACACTCCTCTTATGCAAACACGCCCTTGAGACTTCCGCTGTTTTACTCAGGATCCTGC 801 TGTAGCTGATGCTTAGTAAAGGCTTCCTAGGAAGATCGCAAGTTGAAGGCTCCCCGTGTTATAGAGTGTTCAGGGGATAG 881 CCTGGGTGACTGAGCCAGATCCTGTCTTCCAACAAAAAAAGTGAAGAGAGGGCTGGGCTATCACTCAGTGGTAGAGCATG 961 TGCTCTACCAGTCTTAGGGGCTTCTTGCCTGGTAGGGCTCTCTCTTGGCCTTGTTTTATAAAACGCCTCAAAGTACATAG 1041 GTCTGGGATGGGGAGGGTGGCGGGGCGGCAAGCTTTATGCCCTACTTCCATTGGTGTGATGCATTAACTACTGGGTGTGG 1121 TTTTGGGGTTTTTTGTTTGTTTGTTTCTTTTTTGTTTTTTGCTTTTAATTTGGCTGTACAAAAATAAAATAGAAAAAAGT 1201 GGGGTGGGGTTTTAAAAAAATATACCCCAGGGCATTTTCTGTTAAAAAAATTTCTGCTTCTGGACACAAACTAACTTTTT 1281 TTTTTCAAACATTTTATGCGTGTGGTAGATGCAGTTTGATGTGAACCCACACTGGCAGCTAGTGACTTGGTATGTGTGTT 1361 GTGTCTACTAAGCAGAGATGCCAGTGTGGATGCCAGGTTCACTGTGGTCCAGGAAGCAGAGTGAGTGCTCATGGGAGTAA 1441 TGTTTGTGCAGCTAAGCCAGTATTTTTACTTAAACAAACAAACAAAAAAAGTATACATTTTGCAAAAAAAAAAAAAAAAT 1521 GACGTCCTTTAAATGGTGATGGGCTAATATGTAATATTCTTCAGTTTTAATTATTTTTTAATTTTATTCAATGTAGAGCA 1601 CTTTCTATAGCAATAAAAAAAAACAAAACAAAAAAAAATAAGCAAAGATATTTAAGATTGTATTTATATACCCAGAGTAC 1681 ATTTTAAACATTTTCTAATACTTGAGCAGATGGGTGACTGGCTTCCAGAGATGCCAAAAATTAAACATTCAATACATTCA 1761 ACACATAAGCTTTGTCCTGGTTTGCACAGCCTGGTGAGAATCCTGAGGGTTCCCAGCATAGTTGGCGTTTAGGGTCCCTC 1841 CTCCTCCCTCCTCCCTCAGAAGTTCTGAGGATCCTCGACAAGGTCACTGTCCACGACACTAATGATGGATCGCTTCTTGG 1921 TGTAAAGGAAAGAGTCACTCGGTTGCCATCTTGATGTAAAACATTTTGTAAAGGAAAATTTTTTGGTTTCCAGTGTCAAA 2001 TGTATTTTTAACTGTCTGGTTTGTACTTTTTATGAATTTTGTACTACCAAAGCAGAGTTAAAAATAAAAGCATTAAACCA 2081 GTGTGCTTGAATGAGCGACATCTTACAGGACCAGCTTCTTAAGTCTTCGATTGTTGAGTAATCGTTAGGCTGGTCTGATT 2161 GGATTTCCCCTTTTATAGCACCTCTACCTCCTCCCCCGCCCCCGCCCCATGGATGATTTGGGACATAGAGAAATAAATAT 2241 AGTGTGGAGTTTATGGG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Article |
- Gatfield D; Le Martelot G; Vejnar CE; et al. - Genes & development, 2009
In liver, most metabolic pathways are under circadian control, and hundreds of protein-encoding genes are thus transcribed in a cyclic fashion. Here we show that rhythmic transcription extends to the locus specifying miR-122, a highly abundant, hepatocyte-specific microRNA. Genetic loss-of-function and gain-of-function experiments have identified the orphan nuclear receptor REV-ERBalpha as the major circadian regulator of mir-122 transcription. Although due to its long half-life mature miR-122 accumulates at nearly constant rates throughout the day, this miRNA is tightly associated with control mechanisms governing circadian gene expression. Thus, the knockdown of miR-122 expression via an antisense oligonucleotide (ASO) strategy resulted in the up- and down-regulation of hundreds of mRNAs, of which a disproportionately high fraction accumulates in a circadian fashion. miR-122 has previously been linked to the regulation of cholesterol and lipid metabolism. The transcripts associated with these pathways indeed show the strongest time point-specific changes upon miR-122 depletion. The identification of Pparbeta/delta and the peroxisome proliferator-activated receptor alpha (PPARalpha) coactivator Smarcd1/Baf60a as novel miR-122 targets suggests an involvement of the circadian metabolic regulators of the PPAR family in miR-122-mediated metabolic control.
LinkOut: [PMID: 19487572]
|
86 mmu-miR-122-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT003075 | Tmem50b | transmembrane protein 50B | 1 | 1 | ||||||||
MIRT003076 | Lass6 | ceramide synthase 6 | 1 | 1 | ||||||||
MIRT003077 | Gpx7 | glutathione peroxidase 7 | 1 | 1 | ||||||||
MIRT003113 | Tgfbr1 | transforming growth factor, beta receptor I | 3 | 1 | ||||||||
MIRT003114 | Sbk1 | SH3-binding kinase 1 | 3 | 1 | ||||||||
MIRT003117 | Hist1h1c | histone cluster 1, H1c | 3 | 1 | ||||||||
MIRT003118 | Ddc | dopa decarboxylase | 2 | 1 | ||||||||
MIRT003120 | Rell1 | RELT-like 1 | 3 | 1 | ||||||||
MIRT003121 | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 2 | 1 | ||||||||
MIRT003122 | Apob | apolipoprotein B | 2 | 1 | ||||||||
MIRT003123 | P4ha1 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide | 2 | 1 | ||||||||
MIRT003124 | Ccng1 | cyclin G1 | 2 | 1 | ||||||||
MIRT003125 | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 3 | 3 | ||||||||
MIRT003126 | Gys1 | glycogen synthase 1, muscle | 2 | 2 | ||||||||
MIRT003127 | Slc35a4 | solute carrier family 35, member A4 | 2 | 2 | ||||||||
MIRT003128 | Hfe2 | hemochromatosis type 2 (juvenile) | 3 | 3 | ||||||||
MIRT003129 | Tmed3 | transmembrane p24 trafficking protein 3 | 2 | 2 | ||||||||
MIRT003132 | Bckdk | branched chain ketoacid dehydrogenase kinase | 4 | 1 | ||||||||
MIRT003133 | Aldoa | aldolase A, fructose-bisphosphate | 4 | 7 | ||||||||
MIRT003134 | Ndrg3 | N-myc downstream regulated gene 3 | 4 | 2 | ||||||||
MIRT003135 | Cd320 | CD320 antigen | 4 | 1 | ||||||||
MIRT003724 | Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 3 | 1 | ||||||||
MIRT003725 | Rcan1 | regulator of calcineurin 1 | 2 | 1 | ||||||||
MIRT003726 | Gde1 | glycerophosphodiester phosphodiesterase 1 | 2 | 1 | ||||||||
MIRT004536 | Ccrn4l | nocturnin | 4 | 1 | ||||||||
MIRT005975 | Klf6 | Kruppel-like factor 6 | 4 | 1 | ||||||||
MIRT005976 | B2m | beta-2 microglobulin | 1 | 1 | ||||||||
MIRT005977 | Afp | alpha fetoprotein | 1 | 1 | ||||||||
MIRT005978 | Ccl2 | chemokine (C-C motif) ligand 2 | 1 | 1 | ||||||||
MIRT005979 | Csf3r | colony stimulating factor 3 receptor (granulocyte) | 1 | 1 | ||||||||
MIRT005980 | Ctgf | connective tissue growth factor | 1 | 1 | ||||||||
MIRT005981 | Cxcl13 | chemokine (C-X-C motif) ligand 13 | 1 | 1 | ||||||||
MIRT005982 | Cyp2b13 | cytochrome P450, family 2, subfamily b, polypeptide 13 | 1 | 1 | ||||||||
MIRT005983 | Dbp | D site albumin promoter binding protein | 1 | 1 | ||||||||
MIRT005984 | Igf2 | insulin-like growth factor 2 | 1 | 1 | ||||||||
MIRT005985 | Il1b | interleukin 1 beta | 1 | 1 | ||||||||
MIRT005986 | Jun | jun proto-oncogene | 1 | 1 | ||||||||
MIRT005987 | Per1 | period circadian clock 1 | 1 | 1 | ||||||||
MIRT005988 | Alpl | alkaline phosphatase, liver/bone/kidney | 2 | 1 | ||||||||
MIRT005989 | Cs | citrate synthase | 2 | 1 | ||||||||
MIRT005990 | Prom1 | prominin 1 | 3 | 1 | ||||||||
MIRT005991 | Sox4 | SRY (sex determining region Y)-box 4 | 3 | 1 | ||||||||
MIRT013527 | Uros | uroporphyrinogen III synthase | 1 | 1 | ||||||||
MIRT013528 | Ppox | protoporphyrinogen oxidase | 1 | 1 | ||||||||
MIRT013529 | Urod | uroporphyrinogen decarboxylase | 1 | 1 | ||||||||
MIRT013530 | Cpox | coproporphyrinogen oxidase | 1 | 1 | ||||||||
MIRT013531 | Fech | ferrochelatase | 1 | 1 | ||||||||
MIRT013532 | Hamp | hepcidin antimicrobial peptide | 1 | 1 | ||||||||
MIRT013533 | Tfr2 | transferrin receptor 2 | 1 | 1 | ||||||||
MIRT013534 | Smad4 | SMAD family member 4 | 1 | 1 | ||||||||
MIRT013535 | Smad7 | SMAD family member 7 | 1 | 1 | ||||||||
MIRT013536 | Bmpr1a | bone morphogenetic protein receptor, type 1A | 1 | 1 | ||||||||
MIRT013537 | Hba-a1 | hemoglobin alpha, adult chain 1 | 2 | 1 | ||||||||
MIRT013538 | Hmbs | hydroxymethylbilane synthase | 2 | 1 | ||||||||
MIRT013539 | Mir17 | microRNA 17 | 2 | 1 | ||||||||
MIRT013540 | Alas2 | aminolevulinic acid synthase 2, erythroid | 2 | 1 | ||||||||
MIRT013541 | Mir451 | microRNA 451a | 2 | 1 | ||||||||
MIRT013542 | Tfrc | transferrin receptor | 2 | 1 | ||||||||
MIRT013543 | Socs2 | suppressor of cytokine signaling 2 | 1 | 1 | ||||||||
MIRT013544 | Slc35g1 | solute carrier family 35, member G1 | 1 | 1 | ||||||||
MIRT013545 | Camk2b | calcium/calmodulin-dependent protein kinase II, beta | 1 | 1 | ||||||||
MIRT013546 | Irf6 | interferon regulatory factor 6 | 1 | 1 | ||||||||
MIRT013547 | Rbl2 | RB transcriptional corepressor like 2 | 1 | 1 | ||||||||
MIRT013548 | Hfe | hemochromatosis | 2 | 1 | ||||||||
MIRT013549 | Ccnd1 | cyclin D1 | 2 | 1 | ||||||||
MIRT054338 | Pkm | pyruvate kinase, muscle | 3 | 1 | ||||||||
MIRT054339 | Tfdp2 | transcription factor Dp 2 | 3 | 1 | ||||||||
MIRT054340 | E2f1 | E2F transcription factor 1 | 3 | 1 | ||||||||
MIRT579817 | Zfp113 | zinc finger protein 113 | 1 | 1 | ||||||||
MIRT580378 | Tmem206 | transmembrane protein 206 | 1 | 2 | ||||||||
MIRT581166 | Sec23ip | Sec23 interacting protein | 1 | 1 | ||||||||
MIRT582514 | March5 | membrane-associated ring finger (C3HC4) 5 | 1 | 2 | ||||||||
MIRT586941 | H2-T24 | histocompatibility 2, T region locus 24 | 1 | 2 | ||||||||
MIRT591859 | Iffo2 | intermediate filament family orphan 2 | 1 | 1 | ||||||||
MIRT592160 | Paxip1 | PAX interacting (with transcription-activation domain) protein 1 | 1 | 1 | ||||||||
MIRT592189 | Nanog | Nanog homeobox | 1 | 2 | ||||||||
MIRT592792 | Cdh12 | cadherin 12 | 1 | 1 | ||||||||
MIRT597026 | Thap1 | THAP domain containing, apoptosis associated protein 1 | 1 | 1 | ||||||||
MIRT597210 | Snhg11 | small nucleolar RNA host gene 11 | 1 | 1 | ||||||||
MIRT601300 | Zfp949 | zinc finger protein 949 | 1 | 1 | ||||||||
MIRT602608 | Chrna1 | cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) | 1 | 1 | ||||||||
MIRT602960 | Xpo7 | exportin 7 | 1 | 1 | ||||||||
MIRT603391 | Sgol2 | shugoshin 2A | 1 | 1 | ||||||||
MIRT604008 | Ggps1 | geranylgeranyl diphosphate synthase 1 | 1 | 1 | ||||||||
MIRT605553 | Ppp1r16b | protein phosphatase 1, regulatory (inhibitor) subunit 16B | 1 | 1 | ||||||||
MIRT606204 | Sfxn4 | sideroflexin 4 | 1 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|